![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS11505 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-TAP2/ABCB3 |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human TAP2 (488-530aa) |
產(chǎn)品訂購信息:
英文名稱 Anti-TAP2/ABCB3
中文名稱 ATP結(jié)合轉(zhuǎn)運(yùn)因子2抗體費(fèi)用
別 名 ABC18; ABCB3; Peptide supply factor 2; Peptide transporter PSF2; Peptide transporter TAP2; PSF2; RING 11; TAP 2; Transporter 2 ATP binding cassette sub family B.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子
蛋白分子量 predicted molecular weight: 75kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human TAP2 (488-530aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
ATP結(jié)合轉(zhuǎn)運(yùn)因子2抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 TAP is an integral transmembrane protein involved in the transport of antigens from the cytoplasm to the endoplasmic reticulum for association with MHC class I molecules. It is a heterodimer of TAP1 and TAP2, and the peptide-binding site is shared between the cytoplasmic loops of TAP1 and TAP2. TAP is inducible by interferon gamma and belongs to the ABC transporter family, MDR subfamily. TAP also acts as a molecular scaffold for the final stage of MHC class I folding, namely the binding of peptide. Nascent MHC class I molecules associate with TAP via tapasin. TAP is inhibited by the covalent attachment of herpes simplex virus ICP47 protein, which blocks the peptide-binding site of TAP. It is inhibited by human cytomegalovirus US6 glycoprotein, which binds to the lumenal side of the TAP complex and inhibits peptide translocation by specifically blocking ATP-binding to TAP and prevents the conformational rearrangement of TAP induced by peptide binding.
Subunit : Heterodimer of TAP1 and TAP2. Interacts with Epstein-Barr virus BLNF2a.
Subcellular Location : Membrane; Multi-pass membrane protein.
Similarity : Belongs to the ABC transporter superfamily. ABCB family. MHC peptide exporter (TC 3.A.1.209) subfamily.
Contains 1 ABC transmembrane type-1 domain.
Contains 1 ABC transporter domain.
Anti-sVEGFR2/sFLK-1/FITC 熒光素標(biāo)記可溶性內(nèi)皮生長(zhǎng)因子受體2抗體(人)IgGMulti-class antibodies規(guī)格: 0.2ml
CDK8(Cyclin Dependent Kinase 8) 周期素依賴性激酶8抗原Multi-class antibodies規(guī)格: 0.5mg
CD49(非常晚期抗原)抗體 Anti-CD49/VLA 0.1ml
Phospho-SRC-3 (Thr24) 英文名稱: 磷酸化類固醇受體輔助活化因子-3 0.1ml
EPHA10 英文名稱: 酪酸蛋白激酶受體A10抗體 0.1ml
Rhesus antibody Rh phospho-GIT1(Tyr554) 磷酸化G蛋白偶聯(lián)受體激酶相互作用蛋白1 規(guī)格 0.1ml
CDK8(Cyclin Dependent Kinase 8) 周期素依賴性激酶8抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-PG-C/FITC 熒光素標(biāo)記胃蛋白酶原C抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Mouse Anti-human IgG/Gold 金標(biāo)記小鼠抗人IgG (10nm/15nm)Multi-class antibodies規(guī)格: 2ml
脂肪酸結(jié)合蛋白2抗體 Anti-Fabp2 0.1ml
Rabbit Anti-Goat IgG/HRP 辣根過氧化物酶標(biāo)記的兔抗羊IgG 0.1ml
FPR1 英文名稱: 基肽受體1抗體 0.1ml
Rhesus antibody Rh Phospho-TAK1(Ser412) 磷酸化轉(zhuǎn)化生長(zhǎng)因子β活化激酶1 規(guī)格 0.1ml
Mouse Anti-human IgG/Gold 金標(biāo)記小鼠抗人IgG (10nm/15nm)Multi-class antibodies規(guī)格: 2ml
Penicillin G/BSA 青霉素G偶聯(lián)血清白蛋白Multi-class antibodies規(guī)格: 2mg
Anti-CEAcam8/CD67 癌胚抗原相關(guān)細(xì)胞粘附分子8抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Oct-3/Oct-4 胚胎干細(xì)胞關(guān)鍵蛋白抗體 規(guī)格 0.1ml
WB primary antibody Diluent WB一抗稀釋液 30ml
TUBB5 英文名稱: 微管蛋白β5抗體 0.2ml
C1 Inactivator 英文名稱: 酯酶抑制蛋白C1IN抗體 0.2ml
Anti-CEAcam8/CD67 癌胚抗原相關(guān)細(xì)胞粘附分子8抗體Multi-class antibodies規(guī)格: 0.2ml
BMP2 Protein Human 重組人 BMP-2 蛋白 (Fc 標(biāo)簽)
Calu-3 人(胸膜滲出液)
SLIK4 Others Human 人 SLIK4 / Slik4 人細(xì)胞裂解液 (陽性對(duì)照)
BGC-823-EGFP-puro人細(xì)胞 Human gasic cancer cells BGC-823-EGFP-puro 1640+10% Hyclone滅活血清+2ug/ml puromycin
小鼠;F9
人微內(nèi)皮細(xì)胞 (HCMEC)( 5×105 ) SF9, 昆蟲卵巢細(xì)胞 其它
CL-0467WPMY-1(人正?;|(zhì)永生化細(xì)胞)5×106cells/瓶×2
CXCL16 Others Rat 大鼠 CXCL16 / SR-PSOX 人細(xì)胞裂解液 (陽性對(duì)照)
大鼠虹膜色素上皮細(xì)胞完全培養(yǎng)基 100mL
U-373MG人 U-373MG glioma cells DMEM+10% FBS
IL1B Protein Rabbit 重組兔 IL-1 beta / IL1B 蛋白
NCI-H358(人非小細(xì)胞細(xì)胞) 5×106cells/瓶×2 PC-12(腎上腺嗜鉻細(xì)胞瘤細(xì)胞)
ATP結(jié)合轉(zhuǎn)運(yùn)因子2抗體費(fèi)用 BMP2 Protein Human 重組人 BMP-2 蛋白 (Fc 標(biāo)簽)
Calu-3 人(胸膜滲出液)
SLIK4 Others Human 人 SLIK4 / Slik4 人細(xì)胞裂解液 (陽性對(duì)照)
BGC-823-EGFP-puro人細(xì)胞 Human gasic cancer cells BGC-823-EGFP-puro 1640+10% Hyclone滅活血清+2ug/ml puromycin
小鼠;F9
人微內(nèi)皮細(xì)胞 (HCMEC)( 5×105 ) SF9, 昆蟲卵巢細(xì)胞 其它
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. ATP結(jié)合轉(zhuǎn)運(yùn)因子2抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)ATP結(jié)合轉(zhuǎn)運(yùn)因子2抗體費(fèi)用 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力。抗體的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。